TITLE

TREATMENT OF THROMBOANGIITIS OBLITERANS WITH CLOFIBRATE (ATROMID-S)

AUTHOR(S)
Cotton, R.C.; Craven, J.L.
PUB. DATE
May 1968
SOURCE
Angiology;May1968, Vol. 19 Issue 5, p306
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The effect of treatment of eight patients with thromboangiitis obliterans with clofibrate (Atromid-S) has been studied over a period of 5 months. A statistically highly significant reduction was obtained in the heparin-precipitable fraction following treatment. A significant reduction also occurred in the erythrocyte sedimentation rate, but there was no significant reduction in the plasma fibrinogen concentration. Considerable clinical improvement occurred in three of the patients who were severely affected by superficial thrombophlebitis. The significance of these findings is discussed.
ACCESSION #
16369333

 

Related Articles

  • SOME HEMATOLOGIC DIFFERENCES BETWEEN THROMBOANGIITIS OBLITERANS AND ATHEROSCLEROSIS. Craven, John L.; Cotton, Roy C. // Angiology;Sep1968, Vol. 19 Issue 8, p450 

    Focuses on the hematologic differences between thromobangiitis obliterans and atherosclerosis. Concentration of heparin-precipitable fractions of fibrinogen (HPF) in the plasma of patients with thromobangiitis obliterans; Correlations between HPF and total fibrinogen; Specific nature of the two...

  • Sustained Classic Clinical Spectrum of Thromboangiitis Obliterans (Buerger's Disease). Wysokinski, Waldemar E.; Kwiatkowska, Wieslawa; Sapian-Raczkowska, Bozena; Czamacki, Maciej; Doskocz, Romana; Kowal-Gierczak, Barbara // Angiology;Feb2000, Vol. 51 Issue 2, p141 

    Thromboangiitis obliterans (TAO) has been reported to become less common in general population but more common in women, and in elderly patients. The authors looked at the clinical characteristics of TAO in Poland where there was no significant decrease of smoking and the extent of aging of the...

  • THROMBOPHLEBITIS MIGRANS. Lefemine, Armand A.; Warren, Richard // Angiology;Jun1957, Vol. 8 Issue 3, p266 

    1. Seven patients suffering from phlebitis migrans without impairment of arterial circulation have been studied, 2, None of the patients developed arterial disease during a follow-up period of 8 to 11 years although the vein biopsies in 2 revealed microscopic changes characteristic of Buerger's...

  • Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective—descriptive study in north-east of Iran. Fazeli, Bahare; Modaghegh, Hadi; Ravrai, Hasan; Kazemzadeh, Gholamhossein // Clinical Rheumatology;Jan2008, Vol. 27 Issue 1, p55 

    The pathogenesis of thrombophlebitis migrans is as unknown as the etiology of Buerger’s disease (BD). In the past, thrombophlebitis migrans was a major criterion used in the diagnosis of BD, whereas today it is not as important as before and it is often forgotten to be asked about from...

  • Fibrinogen and Fibrinogen Degradation Product Levels in Thromboangiitis Obliterans. Gulati, Surinder Mohan; Chandra, Vidhan; Narayan, Shashi // Vascular Surgery;Mar1993, Vol. 27 Issue 2, p105 

    Fibrinogen and fibrinogen degradation product levels were estimated in 20 patients with thromboangiitis obliterans and compared with those in healthy smokers and patients with other peripheral vascular diseases. The presence of increased fibrinogen levels in patients with thromboangiitis...

  • Thromboangitis Obliterans: A Clinical Study with Special Emphasis on Venous Involvement. Chopra, B. S.; Zakariah, Thomas; Sodhi, J. S.; Khanna, S. K.; Wahi, P. L. // Angiology;Feb1976, Vol. 27 Issue 2, p126 

    Sixty-one cases of thromboangiitis obliterans (TAO) were studied during 1969–70. Nearly all were males, smokers, of poor socio-economic status. Average age of presentation was 34.2 years. A majority (64%) presented with claudication pain. About one filth gave history of migratory...

  • A challenging case of thromboangiitis obliterans. Abdullah, Ahmad; Hayden, Anna; Gabana, Cori Ann; Appleton, Brent Evan // British Columbia Medical Journal;Apr2016, Vol. 58 Issue 3, p126 

    Thromboangiitis obliterans, or Buerger disease, is a rare, idiopathic, occlusive vascular disease that is strongly associated with smoking and tobacco use. Among patients with peripheral vascular disease, reported prevalence ranges from 45% to 63% in India and 16% to 66% in Korea and Japan, to...

  • Antiphospholipid antibodies in thromboangiitis obliterans. Maslowski, Leszek; McBane, Robert; Alexewicz, Pawel; Wysokinski, Waldemar E // Vascular Medicine;2002, Vol. 7 Issue 4, p259 

    Thromboangiitis obliterans (TAO) and antiphospholipid syndrome (APS) share the clinical characteristics of arterial thrombosis and recurrent thrombophlebitis. Although the association of anticardiolipin antibodies (aCLa) and TAO has been previously recognized, the prevalence and the clinical...

  • Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)? Olin, Jeffrey W // Vascular Medicine;2002, Vol. 7 Issue 4, p257 

    Studies the effect of anticardiolipin antibodies (aCLa) on patients with thromboangiitis obliterans. Role of immunological mechanism in vascular inflammation; Use of double antibody sandwich enzyme-linked immunosorbent assay aCLa.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics